NCT05259462

Group-Based Online Virtual Reality Gaming to Improve Mental Health Among Children With Physical Disabilities

Name: Clinical Trial NCT05259462
Creator: University of Alabama at Birmingham
Keywords: Disability Physical, Intervention, Phase 1, behavioral, clinical trial

Improving Social Isolation and Loneliness Among Children With Physical Disabilities Through Group-Based Online Virtual Reality Gaming

University of Alabama at Birmingham·Phase 1·ClinicalTrials.gov·behavioralNot yet recruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Disability Physical
Drug/Device/Intervention: Intervention
Study type: Interventional
Intervention type: behavioral

Sponsor & location

Primary sponsor: University of Alabama at Birmingham

Timeline & enrollment

Phase: Phase 1
Start date: Jul 01, 2022
End date: Jan 01, 2023
Enrollment: 12 participants

Primary outcome

Changes in Depression,Changes in Social Isolation / Loneliness

Summary

COVID-19 has had a negative impact on the mental health of many children with physical disabilities. This project aims to test the potential effects of an online multiplayer virtual reality group-based, active video game program on social isolation and depression and will include a total of 12 children with physical disabilities.

ICD-10 classifications

Other physical therapyLimitation of activities due to disabilityDependence on wheelchairPostprocedural musculoskeletal disorders, not elsewhere classifiedFamily history of other disabilities and chronic diseases leading to disablement, not elsewhere classified

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT05259462
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT05259462 through Pure Global AI's free database. This Phase 1 trial is sponsored by University of Alabama at Birmingham and is currently Not yet recruiting. The study focuses on Disability Physical. Target enrollment is 12 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.